New type of plaftorm-based biotech company
We aspire to enable Biopharma companies to exceed their goals in developing and delivering lifetransforming nucleic-acid therapies, production processes, as well as GMP manufacturing of biopharmaceutical drug substances.
We are establishing a premier ecosystem to enable network effects, scientific progress, and shared learnings to speed up the availability of biotechnological solutions for serious diseases within infectious diseases, onco-immunology, and precision medicine in rare diseases, concentrating on pilot projects and delivering products for clinical trial activities.
We will provide comprehensive GMP development and the complete spectrum of services from discovery to drug substance and drug product development and manufacturing for New Biological Entities worldwide.
AI/ML DRUG DISCOVERY
SPEED TO MARKET
SCIENTIFIC ADVISORY BOARD
Prof. Sir David Philip Lane
Prof. Ted Hupp
Prof. Robin Fåhraeus
Prof. Philip J. Coates
RNDr. Bořivoj Vojtěšek, DSc.